Overview
What is Eye Tumor Research Foundation Inc?
The Eye Tumor Research Foundation Inc, situated in Philadelphia, Pennsylvania, is a dedicated nonprofit organization focused on exploring malignant melanoma and retinoblastoma tumors affecting the eye. Through research projects, the foundation aims to collect and analyze clinical and demographic data related to these eye tumors' treatment. The objective is to improve treatment methods, visual outcomes, and ultimately decrease mortality rates. The foundation also disseminates the results of its research within the medical community globally. With a team of nine employees, the Eye Tumor Research Foundation Inc is committed to advancing knowledge and enhancing the treatment of eye tumors.
Official website here: www.etrf.org
Is Eye Tumor Research Foundation Inc legitimate?
Eye Tumor Research Foundation Inc is a legitimate nonprofit organization registered as a 501(c)(3) entity. Eye Tumor Research Foundation Inc submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.
Heare are some key statistics you may want to consider:
Executive Compensation: $0
Professional Fundraising Fees: $0
Other Salaries and Wages: $41,050
For more financial information, click here
Official website here: www.etrf.org
What is the mission statement of Eye Tumor Research Foundation Inc?
The Eye Tumor Research Foundation Inc is dedicated to advancing research and education in the field of malignant melanoma and retinoblastoma tumors of the eye. Their primary objective is to improve treatment methods, enhance visual outcomes, and ultimately decrease mortality rates associated with these eye tumors. The foundation accomplishes this by supporting research projects, gathering and analyzing clinical and demographic data, and publishing the results for the benefit of the medical community worldwide. Their mission is to contribute to the betterment of eye tumor treatments, aiming to save lives and improve the quality of life for those affected.
Official website here: www.etrf.org
Who is the CEO of Eye Tumor Research Foundation Inc?
Carol Shields is the President of Eye Tumor Research Foundation Inc.
Official website here: www.etrf.org
What is the revenue of Eye Tumor Research Foundation Inc?
Eye Tumor Research Foundation Inc's revenue in 2022 was $112,489.
Official website here: www.etrf.org
Who are the executives of Eye Tumor Research Foundation Inc and what are their salaries?
The average compensation at Eye Tumor Research Foundation Inc during 2022 was $4,561. There are 9 employees and 9 volunteers at Eye Tumor Research Foundation Inc.
Here are 3 key members and their salaries:
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
Official website here: www.etrf.org
Where can I find the form 990 for Eye Tumor Research Foundation Inc?
Eye Tumor Research Foundation Inc's most recent form 990 was submitted in 2022 and can be accessed here.
Official website here: www.etrf.org
Learn more at the official website: www.etrf.org
Mission Statement of Eye Tumor Research Foundation Inc
The Eye Tumor Research Foundation Inc is dedicated to advancing research and education in the field of malignant melanoma and retinoblastoma tumors of the eye. Their primary objective is to improve treatment methods and enhance visual outcomes for individuals diagnosed with these eye tumors, ultimately aiming to decrease mortality rates. The foundation supports research projects that accumulate and evaluate clinical and demographic data, aiming to contribute to the medical community's understanding and development of more effective treatments. They also actively publish and present the results of their research to share their findings worldwide.
Shop smarter and support your favorite cause with the Give Freely browser extension. Save money with coupons and donate to charity with a single click. Download now!
Impact
October, 2024
Eye Tumor Research Foundation Inc significantly impacts the fields of ophthalmic oncology and patient care by funding critical research projects focused on malignant melanoma and retinoblastoma tumors of the eye. By accumulating and evaluating clinical and demographic data, the foundation aims to enhance treatment methods, improve visual outcomes, and ultimately reduce mortality rates associated with these eye tumors.
Through its commitment to research and education, the foundation actively disseminates findings to the global medical community, ensuring that advancements in treatment and understanding of these cancers reach healthcare professionals and contribute to better patient outcomes. The foundation's efforts not only support innovative treatment approaches but also foster a collaborative environment for ongoing research, improving overall knowledge and expertise in managing these challenging conditions.
This information is meant to be a general summary of Eye Tumor Research Foundation Inc. Please take the time to review official sources before making any decisions based upon the content provided here.
Financials
This financial information is from Propublica.
Other financial information:
This information is from the most recently submitted tax form from this organization, which was in 2022.
- Investment Income: $4,767
- Gross Receipts: $112,489
Assets and Liabilities:
- Total Assets: $862,636
- Total Liabilities: $0
- Net Assets: $862,636
Want to help this charity, for free? You can click here to learn more about Give Freely
Organization Details
Founding Year
1989
Phone
(215) 928-3438Principal Officer
Carol Shields
Main Address
840 WALNUT STREET STE 1440, PHILADELPHIA, PA, 19107
Website
www.etrf.orgNTEE Category
Code: H30 - Medical research
If you are a representative of Eye Tumor Research Foundation Inc and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.